Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gliosarcoma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00016328
What this trial is testing

CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT00003464
What this trial is testing

Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 50
Testing effectiveness (Phase 2)Study completedNCT00005855
What this trial is testing

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 48
Testing effectiveness (Phase 2)Study completedNCT00003185
What this trial is testing

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Study completedNCT00039364
What this trial is testing

Imatinib Mesylate in Treating Patients With Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 112
Early research (Phase 1)UnknownNCT00004129
What this trial is testing

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Center for Molecular Medicine 12
Testing effectiveness (Phase 2)Ended earlyNCT01575275
What this trial is testing

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Michael Vogelbaum, MD, PhD 8
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)UnknownNCT00275067
What this trial is testing

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 50
Testing effectiveness (Phase 2)Study completedNCT00795665
What this trial is testing

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Who this might be right for
Glioma
University of California, Davis 7
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Testing effectiveness (Phase 2)UnknownNCT00009854
What this trial is testing

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Direct Therapeutics
Early research (Phase 1)Study completedNCT00639639
What this trial is testing

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Malignant Neoplasms of Brain
Gary Archer Ph.D. 42
Testing effectiveness (Phase 2)Study completedNCT00553150
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 122
Large-scale testing (Phase 3)Study completedNCT00002545
What this trial is testing

Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 200
Not applicableStudy completedNCT00463008
What this trial is testing

Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 12
Testing effectiveness (Phase 2)Study completedNCT00028678
What this trial is testing

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 45
Testing effectiveness (Phase 2)WithdrawnNCT00006263
What this trial is testing

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Early research (Phase 1)Study completedNCT00019071
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Next Page